BRPI0605833A - pregabalina livre de ácido isobutilglutárico e um processo para sua preparação - Google Patents

pregabalina livre de ácido isobutilglutárico e um processo para sua preparação

Info

Publication number
BRPI0605833A
BRPI0605833A BRPI0605833-7A BRPI0605833A BRPI0605833A BR PI0605833 A BRPI0605833 A BR PI0605833A BR PI0605833 A BRPI0605833 A BR PI0605833A BR PI0605833 A BRPI0605833 A BR PI0605833A
Authority
BR
Brazil
Prior art keywords
pregabalin
preparation
acid free
isobutylglutaric acid
isobutylglutaric
Prior art date
Application number
BRPI0605833-7A
Other languages
English (en)
Inventor
Lilach Hedvati
Ziv Dee Noor
Claude Singer
Gideon Pilarski
Yuriy Raizi
Sharon Tomer
Original Assignee
Teva Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Teva Pharma filed Critical Teva Pharma
Publication of BRPI0605833A publication Critical patent/BRPI0605833A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

PREGABALINA LIVRE DE áCIDO ISOBUTILGLUTáRICO E UM PROCESSO PAPA SUA PREPARAçãO é fornecida uma Pregabalina que apresenta um baixo nível de 3-ácido isobutilglutárico.
BRPI0605833-7A 2005-05-10 2006-05-10 pregabalina livre de ácido isobutilglutárico e um processo para sua preparação BRPI0605833A (pt)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US67978405P 2005-05-10 2005-05-10
US68969905P 2005-06-09 2005-06-09
US73058405P 2005-10-26 2005-10-26
US73143405P 2005-10-27 2005-10-27
US73274505P 2005-11-01 2005-11-01
PCT/US2006/018266 WO2006122255A1 (en) 2005-05-10 2006-05-10 Pregabalin free of isobutylglutaric acid and a process for preparation thereof

Publications (1)

Publication Number Publication Date
BRPI0605833A true BRPI0605833A (pt) 2007-12-18

Family

ID=36954467

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0605833-7A BRPI0605833A (pt) 2005-05-10 2006-05-10 pregabalina livre de ácido isobutilglutárico e um processo para sua preparação

Country Status (9)

Country Link
US (1) US7462737B2 (pt)
EP (1) EP1879853A1 (pt)
JP (1) JP2008505980A (pt)
KR (1) KR20070067077A (pt)
BR (1) BRPI0605833A (pt)
CA (1) CA2604600A1 (pt)
IL (1) IL185028A0 (pt)
MX (1) MX2007000525A (pt)
WO (1) WO2006122255A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1879854B1 (en) 2005-05-10 2011-09-07 Teva Pharmaceutical Industries Ltd Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid
DE602006017995D1 (de) 2005-05-10 2010-12-16 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
WO2007035890A1 (en) 2005-09-19 2007-03-29 Teva Pharmaceutical Industries Ltd. An asymmetric synthesis of ( s ) - ( + ) -3- (aminomethyl) -5-methylhexanoic acid
MX2008014759A (es) 2007-03-22 2009-03-09 Teva Pharma Sintesis del acido (s)-(+)-3-(aminometil)-5-metil hexanoico.
WO2009004643A2 (en) * 2007-05-08 2009-01-08 Cadila Healthcare Limited An improved process for preparation of (s)-pregabalin and intermediates thereof
KR20090101462A (ko) * 2007-10-03 2009-09-28 테바 파마슈티컬 인더스트리즈 리미티드 프레가발린-4-엘리미네이트, 프레가발린 5-엘리미네이트, 기준 마커 및 표준물로서의 이들의 용도, 및 이들을 낮은 수준으로 함유하는 프레가발린의 제조 방법
PT2225198E (pt) * 2007-11-30 2013-01-25 Laboratorio Chimico Int Spa Processos para a preparação de um aminoácido substituído na posição gama
SG176464A1 (en) 2008-05-09 2011-12-29 Agency Science Tech & Res Diagnosis and treatment of kawasaki disease
CA2724828C (en) 2008-05-21 2016-01-12 Sandoz Ag Process for the stereoselective enzymatic hydrolysis of 5-methyl-3-nitromethyl-hexanoic acid ester
WO2009147528A1 (en) * 2008-06-02 2009-12-10 Actavis Group Ptc Ehf Improved process for preparing pregabalin
JPWO2011078172A1 (ja) * 2009-12-25 2013-05-09 株式会社カネカ 光学活性３−置換グルタル酸モノアミドの製造法
EP2383255A1 (en) 2010-04-28 2011-11-02 Lacer, S.A. New compounds, synthesis and use thereof in the treatment of pain
WO2016075082A1 (en) 2014-11-10 2016-05-19 Sandoz Ag Stereoselective reductive amination of alpha-chiral aldehydes using omega-transaminases for the synthesis of precursors of pregabalin and brivaracetam
WO2022256545A1 (en) * 2021-06-04 2022-12-08 Nevakar Injectables Inc. Injectable pregabalin formulations

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0258183B1 (de) * 1986-08-13 1993-03-17 Ciba-Geigy Ag Verfahren zur Herstellung von 5-Amino-4-hydroxyvaleriansäure-Derivaten
US6197819B1 (en) 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
US5616793A (en) * 1995-06-02 1997-04-01 Warner-Lambert Company Methods of making (S)-3-(aminomethyl)-5-methylhexanoic acid
US5637767A (en) 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
DE19530637A1 (de) 1995-08-21 1997-02-27 Bayer Ag Verfahren zur Herstellung von 2,2-Difluorbenzo[1.3]dioxolcarbaldehyden
GB9812413D0 (en) * 1998-06-10 1998-08-05 Glaxo Group Ltd Compound and its use
FR2781793B1 (fr) * 1998-08-03 2001-07-20 Prographarm Lab Procede de fabrication de granules de gabapentine enrobes
HU228815B1 (en) 2000-01-27 2013-05-28 Warner Lambert Co Asymmetric synthesis of pregabalin
DE10203122A1 (de) 2002-01-25 2003-07-31 Gruenenthal Gmbh Verfahren zur Herstellung von substituierten Acrylsäureestern bzw. deren Einsatz zur Herstellung von substituierten gamma-Aminosäuren
US20030225149A1 (en) 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
ES2292107T3 (es) 2004-03-12 2008-03-01 Warner-Lambert Company Llc Ligandos de bifosfina simetricos en c1 y su uso en la sintesis asimetrica de pregabalina.
CA2561755A1 (en) 2004-04-01 2005-10-13 Warner-Lambert Company Llc Preparation of p-chirogenic phospholanes and their use in asymmetric synthesis
UA82292C2 (uk) 2004-04-14 2008-03-25 Пфайзер Продактс Инк. Спосіб стереоселективного біоперетворення аліфатичних динітрилів в ціанокарбонові кислоти (варіанти)
DK1831154T3 (da) * 2004-06-21 2010-04-12 Warner Lambert Co Fremstilling af pregabalin og relaterede forbindelser
WO2006008640A1 (en) 2004-07-15 2006-01-26 Pharmacia & Upjohn Company Llc Non-aqueous suspension containing a drug having an unpleasant taste
CN1634869A (zh) 2004-12-06 2005-07-06 北京阜康仁生物制药科技有限公司 普瑞巴林新晶型及其制备方法
DE602006017995D1 (de) * 2005-05-10 2010-12-16 Teva Pharma Verfahren zur herstellung von pregabalin und salzen daraus
US20060270871A1 (en) 2005-05-30 2006-11-30 Khanduri Chandra H Polymorphic form i of pregabalin and processes for its preparation
CN100410242C (zh) 2005-06-23 2008-08-13 江苏恩华药业股份有限公司 普瑞巴林中间体及其制备方法
CZ297970B6 (cs) 2005-08-10 2007-05-09 Zentiva, A. S Zpusob výroby (S)-3-(aminomethyl)-5-methyl-hexanové kyseliny (pregabalinu)
ITMI20061297A1 (it) 2006-07-04 2008-01-05 Laboratorio Chimico Int Spa Procedimento per la preparazione della'acido (r)-(-)-3-(carbamoilmetil)-5-metilesanoico e del pregabalin e intermedi di sintesi
US20090286880A1 (en) 2006-07-12 2009-11-19 Generics [Uk] Limited Novel process
GB0614133D0 (en) 2006-07-15 2006-08-23 Pliva Istrazivanje I Razvoj D Process for preparing a pharmaceutical compound
US20080014280A1 (en) 2006-07-17 2008-01-17 Glenmark Pharmaceuticals Limited Amorphous pregabalin and process for the preparation thereof

Also Published As

Publication number Publication date
JP2008505980A (ja) 2008-02-28
KR20070067077A (ko) 2007-06-27
CA2604600A1 (en) 2006-11-16
US20060276544A1 (en) 2006-12-07
MX2007000525A (es) 2007-03-28
US7462737B2 (en) 2008-12-09
WO2006122255A1 (en) 2006-11-16
IL185028A0 (en) 2007-12-03
EP1879853A1 (en) 2008-01-23

Similar Documents

Publication Publication Date Title
BRPI0605833A (pt) pregabalina livre de ácido isobutilglutárico e um processo para sua preparação
AR116860A2 (es) Composición que comprende anticuerpo que se fija al dominio ii de her2, y sus variantes ácidas
NI200500164A (es) Nueva difenilazetidinona con caracteristicas fisiologicas mejoradas, correspondiente metodo de produccion, medicamentos que contienen dicho compuesto y su uso.
BRPI0514361A (pt) processo para a produção de dihidropteridinonas
CR20140313A (es) Compuestos de biaril éter urea
CL2007001759A1 (es) Compuesto metformina r-(+) lipoato; mezcla que comprende metformina y acido r-(+) lipoico; composicion farmaceutica que comprende el compuesto; metodo para preparar el compuesto; kit; y uso para tratar la diabetes.
CL2008003910A1 (es) Formulacion liquida, estable, conteniendo anticuerpo que comprende arginina y metionina; procedimiento para inhibir la deamidacion de moleculas de un anticuerpo que comprende agregar arginina a la formulacion liquida.
AR058753A1 (es) Uso de composiciones nutricionales con fosfolipidos esfingolipidos y colesterol
CR9331A (es) Inhibidores de vegf-r2 y metodos
EA200602099A1 (ru) Получение прегабалина и родственных соединений
BR112013020767A2 (pt) composições compreendendo ácido peróxi alfa-cetocarboxílico e métodos para a produção e o uso do mesmo
BRPI0913063A2 (pt) Compostos acilaminoácidos e preparações de alimentos que contém os mesmos
BRPI0908951A2 (pt) compostos de minociclina e método de uso dos mesmos
BRPI0508704A (pt) métodos para a preparação de um composto e para a preparação de calcipotriol ou monoidrato de calcipotriol, composto, e, usos de um composto e de éster dietìlico do ácido (2-ciclopropil-2-oxoetil) fosfÈnico
BRPI0606358A2 (pt) uso de pelo menos um aminoditiol, processo e kit para a deformação permanente dos cabelos e aminotióis
UY27619A1 (es) Ésteres hidroxamato del ácido n-(4-fenil sustituido)- antranílico
CR8993A (es) Procesos e intermediarios para preparar inhibidores de cisteina proteasa
BR0309575A (pt) Processo para a preparação de uma solução aquosa de acrilato de metal alcalino, e, uso de uma solução aquosa de acrilato de metal alcalino
GT200500139A (es) Metodo para la preparacion de acidos hidroxamicos
BRPI0507998A (pt) uso de um inibidor de serina palmitoiltransferase (spt) para tratar aterosclerose e dislipidemia
BRPI0606953A2 (pt) lámpada de descarga de alta pressão e processo para produção de um dispositivo desgaseificador para utilização em uma lámpada
BR112013002204A2 (pt) placa de amostra
BRPI0509917A (pt) alojamento para um circuito a ser implantado in-vivo e processo de produção do mesmo
BRPI0704496A (pt) pigmentos de óxido férrico estáveis à oxidação, processo para a fabricação de pigmentos de óxido férrico, uso dos pigmentos de óxido férrico
EA200900780A1 (ru) Аналоги эпотилона, модифицированные в положениях c12-c13, как противораковые лекарственные средства

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: CONFORME ARTIGO 10O DA RESOLUCAO 124/06, CABE SER ARQUIVADO REFERENTE AO NAO RECOLHIMENTO DA 5A ANUIDADE.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2129 DE 25/10/2011.